Beonchip

🌐 Exciting Growth Ahead for the Organ-on-Chip Market! 🚀 The organ-on-chip (OOC) sector continues on a remarkable growth trajectory, with recent 2025 market reports revealing a bright future for this innovative technology: 📈 Market Growth: According to Grand View Research, the global OOC market, valued at $157.3 million in 2024, is expected to soar at a CAGR of 35.11%, reaching approximately $952.4 million by 2030. Towards Healthcare shares an even more optimistic view, projecting the market to hit $3.24 billion by 2034. This report also highlights the momentum gained in the Asia Pacific region due to an increased investment and rapid innovation that is taking place. At Beonchip, we are thrilled to be part of this rapidly evolving industry, contributing to a future where organ-on-chip technologies revolutionize drug development and personalized medicine. Want to know more? Check the report published by Grand View Research here: https://lnkd.in/dZn3HsUA #OrganOnChip #Innovation #Biotechnology #Microfluidics #Beonchip

Revolutionizing Periodontal Research with Organ-on-a-Chip Technology! 🧬🦷 Exciting advancements in microfluidic organ-on-chip (OoC) systems are transforming periodontal research, offering unprecedented insights into the complex interactions between host tissues and their microenvironments. The review article written by Sriram Gopu Sriram and Hardik Makkar highlights how these innovative technologies simulate dynamic interactions, from oral biofilms to systemic disease connections. Organ-on-chip technology integration in periodontal research can lead to Improved therapeutic strategies for periodontal disease, a chronic condition linked to broader systemic health issues like cardiovascular disease and diabetes. By mimicking real-life biological processes, these systems could be the key to unraveling new treatment avenues and enhancing patient care. The future of oral and systemic health looks brighter than ever! For more information on this review click the url bellow: https://lnkd.in/d8ng73gq #PeriodontalResearch #OrganOnChip #Microfluidics #OralHealth #BiomedicalInnovation

🔬 Accelerating Innovation in Non-Animal Testing: Open Access to High Throughput Screening The EURL ECVAM High Throughput Testing (HTT) Laboratory is now offering open access to researchers and institutions looking to automate and validate in vitro methods for chemical and pharmaceutical testing—advancing non-animal approaches in regulatory safety assessment. Equipped with cutting-edge automation, including robotic liquid handling, high-content imaging, and multiplexed plate readers, the facility provides unparalleled capabilities for high-precision testing. Researchers can leverage this infrastructure to: ✅ Improve the automation and reliability of in vitro methods ✅ Generate large-scale datasets for regulatory applications ✅ Accelerate the adoption of animal-free testing strategies ✅ Collaborate and share scientific expertise 📢 The call for proposals is now open! If you're working on innovative in vitro models and need access to a world-class HTT facility, don’t miss this opportunity. 📩 More details and application information: https://lnkd.in/dE8BqjrK #NonAnimalTesting #InVitroMethods #RegulatoryScience #Toxicology #HTT #Innovation #EURL_ECVAM

🔬 Advancing Cancer Research with Organ-on-Chip Technology Cancer remains one of the greatest challenges in modern medicine. Investing in research is not just necessary—it is critical to developing better treatments and improving patient outcomes. At Beonchip, we are very proud to see our customers contribute to the cause. Recently, two scientific studies have been published using our Be-Gradient Barrier-free chip to better understand tumor biology and test potential therapies. These breakthroughs highlight the growing role of microfluidics in creating more physiologically relevant cancer models, helping researchers get closer to new treatments. Here are the links to the two new publications: 1) A Novel Multicompartment Barrier-Free Microfluidic Device Reveals the Impact of Extracellular Matrix Stiffening and Temozolomide on Immune-Tumor Interactions in Glioblastoma https://lnkd.in/dEWXByvr 2) Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor-on-a-chip platform https://lnkd.in/d3cRkeN7 #CancerResearch #OrganOnChip #Beonchip #InnovationInScience #InvestInResearch

💡 "At Beonchip, science is female! 👩🔬💙" Today, on the International Day of Women and Girls in Science, we celebrate the amazing women in our team who make up over 85% of our workforce, all with a strong scientific background. Their dedication, talent, and innovation drive our breakthroughs in organ-on-chip technology. 🔬 Science needs diversity. Innovation thrives with inclusion. And the future of biotech is brighter when everyone has a seat at the lab bench! 📢 To all the girls aspiring to be scientists—keep dreaming, keep questioning, and keep breaking barriers! 🚀 #WomenInScience #GirlsInSTEM #Beonchip #Innovation

Today, we celebrate 9 years since the foundation of Beonchip S.L. It’s incredible to reflect on how far we’ve come—step by step, challenge by challenge, innovation by innovation. Every small milestone has shaped us into what we are today: a company proud to contribute to scientific progress by reducing barriers to organ-on-chip technology. Our mission has always been clear—lowering the entry barriers to organ-on-chip researchers and creating a new generation of in vitro platforms for a more efficient and ethical biomedical research. Thank you to everyone who’s been part of this journey—our team, collaborators, and clients. Here’s to the discoveries we’ve supported, the challenges we’ve overcome, and the future breakthroughs yet to come. 🥂 #Beonchip #9thAnniversary #OrganOnChip #Innovation #Science

We are pleased to begin the year on a high note by welcoming Catarina Coutinho as the newest member of the Beonchip team! Catarina holds an Integrated Master in Bioengineering – Molecular Biotechnology from the University of Porto and recently completed her PhD in Advanced Materials and Nanotechnology at Universidad Autónoma de Madrid. Her impressive background includes the development of polymeric, gold, and protein-based nanoparticles for drug delivery, cancer molecular diagnosis, and gene editing-based therapies. With research experience at i3S/INEB and IMDEA Nanoscience, Catarina brings extensive expertise in cutting-edge nanotechnology solutions. We are excited to have her on board and look forward to achieving new milestones together in the field of microfluidics and advanced materials! Welcome, Catarina! 🎉 #WelcomeToTheTeam #Innovation #Nanotechnology #Bioengineering #Beonchip #TeamGrowth #CancerResearch

🎄 Happy Holidays from Beonchip! 🎄 As the year comes to a close, we want to thank all of you—our partners, clients, and supporters—for being part of our journey. Wishing you a joyful holiday season and a successful year ahead! Here’s to innovation, collaboration, and growth in 2025. 🎉 #HappyHolidays #ThankYou #Beonchip #Innovation

As we approach the end of the year, the Beonchip team gathered at La Zarola for an exciting team activity. A heartfelt thank you to everyone for your hard work and commitment to advancing our mission. As we take this time to recharge and spend the holidays with our loved ones, we remain focused on our goal of lowering the barriers to implementing organ-on-chip platforms in every biomedical laboratory. We look forward to returning in 2025 with renewed energy to drive innovation and continue making a meaningful impact. Wishing you all a joyful holiday season and a successful start to the new year. #Beonchip #OrganOnChip #Innovation #Teamwork #HappyHolidays"

Advancing Tumor Detection with Beonchip’s Be-Gradient Barrier-Free Device 🔬 Liquid biopsies are transforming cancer diagnostics, offering a minimally invasive way to detect, monitor, and characterize tumors. However, accurately replicating in vivo conditions for volatile organic compound (VOC) detection remains a challenge—until now. Our Be-Gradient Barrier-Free device overcomes these limitations. By using cyclic olefin polymer (COP) with low gas permeability, we ensure precise control of oxygen and water vapor exchange within the microchannel. This innovation mimics the gas gradients found in solid tumors, enabling reliable VOC detection as biomarkers for early tumor detection, particularly in hard-to-access cancers like glioblastoma. This advances conducted by Clara Bayona Royo at the TMElab opens new possibilities for real-time tumor monitoring and improved patient outcomes. Do you want to learn more about VOC detection using the Be-Gradient Barrier-free? Check out our technical note on the topic here: https://lnkd.in/dauvaBFJ #Innovation #CancerResearch #LiquidBiopsy #TumorBiomarkers #VOCDetection #Beonchip #Microfluidics #Glioblastoma #OrganOnChip